Your browser doesn't support javascript.
loading
[Use of botulinum toxin A in pelvic floor dysfunctions in the elderly: A review]. / Intérêt de la toxine botulinique A dans le traitement des troubles pelvi-périnéaux de la personne âgée.
Biardeau, X; Haddad, R; Chesnel, C; Charlanes, A; Hentzen, C; Turmel, N; Campagne, S; Capon, G; Fatton, B; Gamé, X; Jeandel, C; Kerdraon, J; Mares, P; Mezzadri, M; Petit, A-C; Peyronnet, B; Soler, J-M; Thuillier, C; Deffieux, X; Robain, G; Amarenco, G; Manceau, P.
Afiliação
  • Biardeau X; Service d'urologie et d'andrologie, hôpital Claude-Huriez, université Lille, CHU Lille, 59000 Lille, France. Electronic address: biardeau.xavier@gmail.com.
  • Haddad R; Service de médecine physique et réadaptation, hôpital Rotschild, 75012 Paris, France.
  • Chesnel C; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de neuro-urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Charlanes A; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de neuro-urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Hentzen C; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de neuro-urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Turmel N; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de neuro-urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Campagne S; Service de gynécologie, CHU Estaing, 63003 Clermont-Ferrand, France.
  • Capon G; Service d'urologie, centre hospitalier Pellegrin, 33076 Bordeaux, France.
  • Fatton B; Service de gynécologie, CHU de Nîmes, 30000 Nîmes, France.
  • Gamé X; Service d'urologie, transplantation rénale et andrologie, CHU Rangueil, 31000 Toulouse, France.
  • Jeandel C; Service de gériatrie, CHU de Montpellier, 34000 Montpellier, France.
  • Kerdraon J; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Centre mutualiste de rééducation et réadaptation Kerpape, BP 78, 56275 Ploemeur cedex, France.
  • Mares P; Service d'urologie, CHRU Carémeau, 30029 Nîmes cedex 9, France.
  • Mezzadri M; Service de gynécologie, hôpital Lariboisière, AP-HP, 75010 Paris, France.
  • Petit AC; Centre de santé, 8, rue Neibecker, 93440 Dugny, France.
  • Peyronnet B; Service d'urologie, CHU de Rennes, 35000 Rennes, France.
  • Soler JM; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de médecine physique et réadaptation, centre Bouffard-Vercelli, 66290 Cerbère, France.
  • Thuillier C; Service d'urologie, CHU de Grenoble, 38700 La Tronche, France.
  • Deffieux X; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de gynécologie, hôpital Antoine-Béclère, AP-HP, 92140 Clamart, France.
  • Robain G; Service de médecine physique et réadaptation, hôpital Rotschild, 75012 Paris, France; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France.
  • Amarenco G; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de neuro-urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
  • Manceau P; GRC 01, Green-groupe de recherche clinique en neuro-urologie, hôpital Tenon, Sorbonne universités, AP-HP, 75020 Paris, France; Service de neuro-urologie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France; Service de neurologie, hôpital Avicennes, 93000 Bobigny, France.
Prog Urol ; 29(4): 216-225, 2019 Mar.
Article em Fr | MEDLINE | ID: mdl-30621961
ABSTRACT

INTRODUCTION:

The present article is the final report of a multi-disciplinary meeting supported by the GRAPPPA (group for research applied to pelvic floor dysfunctions in the elderly). The objective was to conduct a comprehensive review on the role of botulinum toxin A (BonTA) in the treatment of pelvic floor dysfunctions in the elderly.

METHODS:

The present article, written as a comprehensive review of the literature, combines data issued from the scientific literature with expert's opinions. Review of the literature was performed using the online bibliographic database MedLine (National Library of Medicine). Regarding intra-detrusor BonTA injections, only articles focusing on elderly patients (>65 yo) were included. Regarding other localizations, given the limited number of data, all articles reporting outcomes of BonTA were included, regardless of studies population age. In case of missing or insufficient data, expert's opinions were formulated.

RESULTS:

Although, available data are lacking in this specific population, it appears that BonTA could be used in the non-fraily elderly patients to treat overactive bladder or even neurogenic detrusor overactivity, with a success rate comparable to younger population at 3 months (88.9% vs. 91.2%), 6 months (49.4% vs. 52.1%) and 12 months (23.1% vs. 22.3%), as well as a significant decrease in number of voids per day (11.4 vs. 5.29 P<0.001) and in the number of pads per day (4.0 vs. 1.3, P<0.01). Furthermore, BonTA is likely to be offered in the future as a treatment of fecal incontinence and obstructed defecation syndrome symptoms. Concerning bladder outlet obstruction/voiding dysfunction symptoms, intra-urethral sphincter BonTA should not be recommended.

CONCLUSION:

BonTA injections are of interest in the management of various pelvic floor dysfunctions in the elderly, and its various applications should be better evaluated in this specific population in order to further determine its safety and efficacy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / Distúrbios do Assoalho Pélvico / Fármacos Neuromusculares Limite: Aged / Humans Idioma: Fr Revista: Prog Urol Assunto da revista: UROLOGIA Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / Distúrbios do Assoalho Pélvico / Fármacos Neuromusculares Limite: Aged / Humans Idioma: Fr Revista: Prog Urol Assunto da revista: UROLOGIA Ano de publicação: 2019 Tipo de documento: Article